Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) — St Louis, Missouri

Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) is a clinical research site located in St Louis, Missouri, United States 63141.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) has participated in 1 clinical trials.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St Louis

Browse all research sites in Missouri · View every site in St Louis

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095)?

Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) conducted?

Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) has 1 clinical trials on record. Their work covers Urothelial Carcinoma.

Is Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) accredited by Crixeo Clinical Trials?

Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Hospital Saint Louis - David C. Pratt Cancer Center ( Site 0095)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.